These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36031013)

  • 1. Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction.
    Wang B; Tan Y; Zhou W; Yang J; Jiang Y; Liu X; Zhan Z
    Matrix Biol; 2022 Sep; 112():171-189. PubMed ID: 36031013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart.
    Humeres C; Shinde AV; Tuleta I; Hernandez SC; Hanna A; Huang S; Venugopal H; Aguilan JT; Conway SJ; Sidoli S; Frangogiannis NG
    Circ Res; 2024 Jul; 135(3):453-469. PubMed ID: 38899461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
    Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
    J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression.
    Wang B; Tan Y; Zhang Y; Zhang S; Duan X; Jiang Y; Li T; Zhou Q; Liu X; Zhan Z
    Exp Mol Med; 2022 Dec; 54(12):2175-2187. PubMed ID: 36481938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways.
    Cheng X; Wang L; Wen X; Gao L; Li G; Chang G; Qin S; Zhang D
    EBioMedicine; 2021 May; 67():103370. PubMed ID: 33971401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
    Humeres C; Shinde AV; Hanna A; Alex L; Hernández SC; Li R; Chen B; Conway SJ; Frangogiannis NG
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34905511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
    Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
    Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice.
    Goh KY; He L; Song J; Jinno M; Rogers AJ; Sethu P; Halade GV; Rajasekaran NS; Liu X; Prabhu SD; Darley-Usmar V; Wende AR; Zhou L
    Redox Biol; 2019 Feb; 21():101100. PubMed ID: 30641298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
    Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
    Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.
    Verjans R; Peters T; Beaumont FJ; van Leeuwen R; van Herwaarden T; Verhesen W; Munts C; Bijnen M; Henkens M; Diez J; de Windt LJ; van Nieuwenhoven FA; van Bilsen M; Goumans MJ; Heymans S; González A; Schroen B
    Hypertension; 2018 Feb; 71(2):280-288. PubMed ID: 29255073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.
    Uchinaka A; Kawaguchi N; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N
    Cardiovasc Res; 2013 Jul; 99(1):102-10. PubMed ID: 23615564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by β-arrestins.
    Philip JL; Xu X; Han M; Akhter SA; Razzaque MA
    PLoS One; 2019; 14(7):e0219011. PubMed ID: 31269046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.
    O'Riordan CE; Purvis GSD; Collotta D; Chiazza F; Wissuwa B; Al Zoubi S; Stiehler L; Martin L; Coldewey SM; Collino M; Thiemermann C
    Front Immunol; 2019; 10():2129. PubMed ID: 31552054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β Signaling.
    Kim J; Kim J; Lee SH; Kepreotis SV; Yoo J; Chun JS; Hajjar RJ; Jeong D; Park WJ
    PLoS One; 2016; 11(11):e0166480. PubMed ID: 27835665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM kinase 2 activates cardiac fibroblasts and exacerbates postinfarction left ventricular remodeling via crosstalk between the canonical and non-canonical Wnt pathways.
    Gong C; Chang L; Huang R; Sun X; Liu Y; Wu S; Wang L; Xu B; Wang L
    Pharmacol Res; 2024 Oct; 208():107347. PubMed ID: 39153710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.
    Chen YH; Wang Q; Li CY; Hou JW; Chen XM; Zhou Q; Chen J; Wang YP; Li YG
    J Mol Cell Cardiol; 2017 Apr; 105():1-11. PubMed ID: 28214509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.